
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
	<head>


<!-- Start Wayback Rewrite JS Include -->
<script type="text/javascript" src="/static/js/jwplayer/jwplayer.js" ></script>
<script type="text/javascript" src="/static/js/video-embed-rewriter.js"></script>
<script type="text/javascript">
function initYTVideo(id)
{
	_wmVideos_.init("/web/", id);
}
</script>
<!-- End Wayback Rewrite JS Include -->
<title>
	2010 FDA Decisions to Watch (AMLN, DNDN, LLY, MNKD, VVUS)
</title><meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
	<meta http-equiv="imagetoolbar" content="no" />
	
	

<link href="/web/20100104083858cs_/http://g.fool.com/common/css/Fool.css?v=62615b" rel="stylesheet" type="text/css" media="all" />
	<link href="/web/20100104083858cs_/http://g.fool.com/common/css/Usmf.css?v=62615b" rel="stylesheet" type="text/css" media="all" />
	
	
	<link href="/web/20100104083858cs_/http://g.fool.com/css/WWW.css?v=62615b" rel="stylesheet" type="text/css" media="all" />
	<link href="/web/20100104083858cs_/http://g.fool.com/Common/Css/Widgets/Hover/v1/Theme.css?v=62615b" rel="stylesheet" type="text/css" media="all" />
	
	<link href="/web/20100104083858cs_/http://g.fool.com/css/Article.css?v=62615b" rel="stylesheet" type="text/css" media="screen" />
	<link href="/web/20100104083858cs_/http://g.fool.com/css/modules/mom.css?v=62615b" rel="stylesheet" type="text/css" media="screen" />



	
	
			<script type='text/javascript'>
			var isUserNameCreated = false;
			var isLoggedIn = false;
			var hasUserName = false;
			var isRegistered = false;
			</script><script src="/web/20100104083858js_/http://g.fool.com/common/js/Prototype/1.6.1/prototype.min.js?v=62615b" type="text/javascript"></script><script src="/web/20100104083858js_/http://g.fool.com/common/js/Fool.min.js?v=62615b" type="text/javascript"></script>
	<script src="/web/20100104083858js_/http://g.fool.com/common/js/Fx/Fx.min.js?v=62615b" type="text/javascript"></script>
	<script src="/web/20100104083858js_/http://g.fool.com/common/js/Usmf.js?v=62615b" type="text/javascript"></script>
	<script type="text/javascript">
		Fool.onContent(function() {
			//UsmfAuth = new Usmf.Authentication();
		});
	</script>
	<!--[if IE 6]>
	<script src="/web/20100104083858/http://g.fool.com/common/js/DD_belatedPNG_0.0.3a.min.js" type="text/javascript"></script>
	<![endif]-->
	
	<script src="/web/20100104083858js_/http://g.fool.com/js/WWW.min.js?v=62615b" type="text/javascript"></script>
	
	<script src="/web/20100104083858js_/http://g.fool.com/common/js/Fx/Fx.Expando.min.js?v=62615b" type="text/javascript"></script>
	<script src="/web/20100104083858js_/http://g.fool.com/js/Article.js?v=62615b" type="text/javascript"></script>
	<script src="/web/20100104083858js_/http://g.fool.com/Common/js/Controls/Recommendations.min.js?v=62615b" type="text/javascript"></script>
	<script type="text/javascript">Article.prepare();</script>


<meta name="headline" content="2010 FDA Decisions to Watch" /><meta name="STORY_UID" content="rx39841" /><meta name="description" content="The Motley Fool - It's a pivotal year for these drugmakers." /><meta name="author" content="Brian Orelli" /><meta name="articletype" content="Investing" /><meta name="collection" content="Investing" /><meta name="date" content="2009-12-31T14:23:56-05:00" /><meta name="promo" /><meta name="tickers" content="AMLN,DNDN,LLY,MNKD,VVUS,MRK,PFE" /><meta name="gsa_date" content="2009-12-31" /></head>
	
	<body id="ctl01_ctl00_ctl00_ctl00_ctl00_ctl00_cphContent_Body" class="hlp Default collectionInvesting">
<!-- BEGIN WAYBACK TOOLBAR INSERT -->

<script type="text/javascript" src="/static/js/disclaim-element.js" ></script>
<script type="text/javascript" src="/static/js/graph-calc.js" ></script>
<script type="text/javascript" src="/static/jflot/jquery.min.js" ></script>
<script type="text/javascript">
//<![CDATA[
var firstDate = 820454400000;
var lastDate = 1388534399999;
var wbPrefix = "/web/";
var wbCurrentUrl = "http:\/\/www.fool.com\/investing\/general\/2009\/12\/31\/2010-fda-decisions-to-watch.aspx";

var curYear = -1;
var curMonth = -1;
var yearCount = 18;
var firstYear = 1996;
var imgWidth = 450;
var yearImgWidth = 25;
var monthImgWidth = 2;
var trackerVal = "none";
var displayDay = "4";
var displayMonth = "Jan";
var displayYear = "2010";
var prettyMonths = ["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"];

function showTrackers(val) {
	if(val == trackerVal) {
		return;
	}
	if(val == "inline") {
		document.getElementById("displayYearEl").style.color = "#ec008c";
		document.getElementById("displayMonthEl").style.color = "#ec008c";
		document.getElementById("displayDayEl").style.color = "#ec008c";		
	} else {
		document.getElementById("displayYearEl").innerHTML = displayYear;
		document.getElementById("displayYearEl").style.color = "#ff0";
		document.getElementById("displayMonthEl").innerHTML = displayMonth;
		document.getElementById("displayMonthEl").style.color = "#ff0";
		document.getElementById("displayDayEl").innerHTML = displayDay;
		document.getElementById("displayDayEl").style.color = "#ff0";
	}
   document.getElementById("wbMouseTrackYearImg").style.display = val;
   document.getElementById("wbMouseTrackMonthImg").style.display = val;
   trackerVal = val;
}
function getElementX2(obj) {
	var thing = jQuery(obj);
	if((thing == undefined) 
			|| (typeof thing == "undefined") 
			|| (typeof thing.offset == "undefined")) {
		return getElementX(obj);
	}
	return Math.round(thing.offset().left);
}
function trackMouseMove(event,element) {

   var eventX = getEventX(event);
   var elementX = getElementX2(element);
   var xOff = eventX - elementX;
	if(xOff < 0) {
		xOff = 0;
	} else if(xOff > imgWidth) {
		xOff = imgWidth;
	}
   var monthOff = xOff % yearImgWidth;

   var year = Math.floor(xOff / yearImgWidth);
	var yearStart = year * yearImgWidth;
   var monthOfYear = Math.floor(monthOff / monthImgWidth);
   if(monthOfYear > 11) {
       monthOfYear = 11;
   }
   // 1 extra border pixel at the left edge of the year:
   var month = (year * 12) + monthOfYear;
   var day = 1;
	if(monthOff % 2 == 1) {
		day = 15;
	}
	var dateString = 
		zeroPad(year + firstYear) + 
		zeroPad(monthOfYear+1,2) +
		zeroPad(day,2) + "000000";

	var monthString = prettyMonths[monthOfYear];
	document.getElementById("displayYearEl").innerHTML = year + 1996;
	document.getElementById("displayMonthEl").innerHTML = monthString;
	// looks too jarring when it changes..
	//document.getElementById("displayDayEl").innerHTML = zeroPad(day,2);

	var url = wbPrefix + dateString + '/' +  wbCurrentUrl;
	document.getElementById('wm-graph-anchor').href = url;

   //document.getElementById("wmtbURL").value="evX("+eventX+") elX("+elementX+") xO("+xOff+") y("+year+") m("+month+") monthOff("+monthOff+") DS("+dateString+") Moy("+monthOfYear+") ms("+monthString+")";
   if(curYear != year) {
       var yrOff = year * yearImgWidth;
       document.getElementById("wbMouseTrackYearImg").style.left = yrOff + "px";
       curYear = year;
   }
   if(curMonth != month) {
       var mtOff = year + (month * monthImgWidth) + 1;
       document.getElementById("wbMouseTrackMonthImg").style.left = mtOff + "px";
       curMonth = month;
   }
}
//]]>
</script>

<style type="text/css">body{margin-top:0!important;padding-top:0!important;min-width:800px!important;}#wm-ipp a:hover{text-decoration:underline!important;}</style>
<div id="wm-ipp" style="display:none; position:relative;padding:0 5px;min-height:70px;min-width:800px; z-index:9000;">
<div id="wm-ipp-inside" style="position:fixed;padding:0!important;margin:0!important;width:97%;min-width:780px;border:5px solid #000;border-top:none;background-image:url(/static/images/toolbar/wm_tb_bk_trns.png);text-align:center;-moz-box-shadow:1px 1px 3px #333;-webkit-box-shadow:1px 1px 3px #333;box-shadow:1px 1px 3px #333;font-size:11px!important;font-family:'Lucida Grande','Arial',sans-serif!important;">
   <table style="border-collapse:collapse;margin:0;padding:0;width:100%;"><tbody><tr>
   <td style="padding:10px;vertical-align:top;min-width:110px;">
   <a href="/web/" title="Wayback Machine home page" style="background-color:transparent;border:none;"><img src="/static/images/toolbar/wayback-toolbar-logo.png" alt="Wayback Machine" width="110" height="39" border="0"/></a>
   </td>
   <td style="padding:0!important;text-align:center;vertical-align:top;width:100%;">

       <table style="border-collapse:collapse;margin:0 auto;padding:0;width:570px;"><tbody><tr>
       <td style="padding:3px 0;" colspan="2">
       <form target="_top" method="get" action="/web/form-submit.jsp" name="wmtb" id="wmtb" style="margin:0!important;padding:0!important;"><input type="text" name="url" id="wmtbURL" value="http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" style="width:400px;font-size:11px;font-family:'Lucida Grande','Arial',sans-serif;" onfocus="javascript:this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20100104083858" /><input type="submit" value="Go" style="font-size:11px;font-family:'Lucida Grande','Arial',sans-serif;margin-left:5px;" /><span id="wm_tb_options" style="display:block;"></span></form>
       </td>
       <td style="vertical-align:bottom;padding:5px 0 0 0!important;" rowspan="2">
           <table style="border-collapse:collapse;width:110px;color:#99a;font-family:'Helvetica','Lucida Grande','Arial',sans-serif;"><tbody>
			
           <!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
           <tr style="width:110px;height:16px;font-size:10px!important;">
           	<td style="padding-right:9px;font-size:11px!important;font-weight:bold;text-transform:uppercase;text-align:right;white-space:nowrap;overflow:visible;" nowrap="nowrap">
               
                       Dec
                       
               </td>
               <td id="displayMonthEl" style="background:#000;color:#ff0;font-size:11px!important;font-weight:bold;text-transform:uppercase;width:34px;height:15px;padding-top:1px;text-align:center;" title="You are here: 8:38:58 Jan 4, 2010">JAN</td>
				<td style="padding-left:9px;font-size:11px!important;font-weight:bold;text-transform:uppercase;white-space:nowrap;overflow:visible;" nowrap="nowrap">
               
		                <a href="/web/20100219081640/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" style="text-decoration:none;color:#33f;font-weight:bold;background-color:transparent;border:none;" title="19 Feb 2010"><strong>FEB</strong></a>
		                
               </td>
           </tr>

           <!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
           <tr>
               <td style="padding-right:9px;white-space:nowrap;overflow:visible;text-align:right!important;vertical-align:middle!important;" nowrap="nowrap">
               
                       <img src="/static/images/toolbar/wm_tb_prv_off.png" alt="Previous capture" width="14" height="16" border="0" />
                       
               </td>
               <td id="displayDayEl" style="background:#000;color:#ff0;width:34px;height:24px;padding:2px 0 0 0;text-align:center;font-size:24px;font-weight: bold;" title="You are here: 8:38:58 Jan 4, 2010">4</td>
				<td style="padding-left:9px;white-space:nowrap;overflow:visible;text-align:left!important;vertical-align:middle!important;" nowrap="nowrap">
               
		                <a href="/web/20100121010840/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" title="1:08:40 Jan 21, 2010" style="background-color:transparent;border:none;"><img src="/static/images/toolbar/wm_tb_nxt_on.png" alt="Next capture" width="14" height="16" border="0"/></a>
		                
			    </td>
           </tr>

           <!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
           <tr style="width:110px;height:13px;font-size:9px!important;">
				<td style="padding-right:9px;font-size:11px!important;font-weight: bold;text-align:right;white-space:nowrap;overflow:visible;" nowrap="nowrap">
               
                       2009
                       
               </td>
               <td id="displayYearEl" style="background:#000;color:#ff0;font-size:11px!important;font-weight: bold;padding-top:1px;width:34px;height:13px;text-align:center;" title="You are here: 8:38:58 Jan 4, 2010">2010</td>
				<td style="padding-left:9px;font-size:11px!important;font-weight: bold;white-space:nowrap;overflow:visible;" nowrap="nowrap">
               
		                <a href="/web/20110430025946/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" style="text-decoration:none;color:#33f;font-weight:bold;background-color:transparent;border:none;" title="30 Apr 2011"><strong>2011</strong></a>
		                
				</td>
           </tr>
           </tbody></table>
       </td>

       </tr>
       <tr>
       <td style="vertical-align:middle;padding:0!important;">
           <a href="/web/20100104083858*/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" style="color:#33f;font-size:11px;font-weight:bold;background-color:transparent;border:none;" title="See a list of every capture for this URL"><strong>16 captures</strong></a>
           <div style="margin:0!important;padding:0!important;color:#666;font-size:9px;padding-top:2px!important;white-space:nowrap;" title="Timespan for captures of this URL">4 Jan 10 - 3 Feb 13</div>
       </td>
       <td style="padding:0!important;">
       <a style="position:relative; white-space:nowrap; width:450px;height:27px;" href="" id="wm-graph-anchor">
       <div id="wm-ipp-sparkline" style="position:relative; white-space:nowrap; width:450px;height:27px;background-color:#fff;cursor:pointer;border-right:1px solid #ccc;" title="Explore captures for this URL">
			<img id="sparklineImgId" style="position:absolute; z-index:9012; top:0px; left:0px;"
				onmouseover="showTrackers('inline');" 
				onmouseout="showTrackers('none');"
				onmousemove="trackMouseMove(event,this)"
				alt="sparklines"
				width="450"
				height="27"
				border="0"
				src="/web/jsp/graph.jsp?graphdata=450_27_1996:-1:000000000000_1997:-1:000000000000_1998:-1:000000000000_1999:-1:000000000000_2000:-1:000000000000_2001:-1:000000000000_2002:-1:000000000000_2003:-1:000000000000_2004:-1:000000000000_2005:-1:000000000000_2006:-1:000000000000_2007:-1:000000000000_2008:-1:000000000000_2009:-1:000000000000_2010:0:211111000000_2011:-1:000100011000_2012:-1:000000400100_2013:-1:010000000000"></img>
			<img id="wbMouseTrackYearImg" 
				style="display:none; position:absolute; z-index:9010;"
				width="25" 
				height="27"
				border="0"
				src="/static/images/toolbar/transp-yellow-pixel.png"></img>
			<img id="wbMouseTrackMonthImg"
				style="display:none; position:absolute; z-index:9011; " 
				width="2"
				height="27" 
				border="0"
				src="/static/images/toolbar/transp-red-pixel.png"></img>
       </div>
		</a>

       </td>
       </tr></tbody></table>
   </td>
   <td style="text-align:right;padding:5px;width:65px;font-size:11px!important;">
       <a href="javascript:;" onclick="document.getElementById('wm-ipp').style.display='none';" style="display:block;padding-right:18px;background:url(/static/images/toolbar/wm_tb_close.png) no-repeat 100% 0;color:#33f;font-family:'Lucida Grande','Arial',sans-serif;margin-bottom:23px;background-color:transparent;border:none;" title="Close the toolbar">Close</a>
       <a href="http://faq.web.archive.org/" style="display:block;padding-right:18px;background:url(/static/images/toolbar/wm_tb_help.png) no-repeat 100% 0;color:#33f;font-family:'Lucida Grande','Arial',sans-serif;background-color:transparent;border:none;" title="Get some help using the Wayback Machine">Help</a>
   </td>
   </tr></tbody></table>

</div>
</div>
<script type="text/javascript">
 var wmDisclaimBanner = document.getElementById("wm-ipp");
 if(wmDisclaimBanner != null) {
   disclaimElement(wmDisclaimBanner);
 }
</script>
<!-- END WAYBACK TOOLBAR INSERT -->

		
		
	<div id="header" class="navCellA">
			
				
		   

<div id="tophat" class="clearfix">
  <div class="grid">
    <div id="tophatWrap">
	<div id="navigation" class="clearfix">
		<a class="qsAdd qs-source-iflsittph0000001" href="/web/20100104083858/http://www.fool.com/"><span class="fool">Fool.com</span></a>
		<span id="quips">The #1 Community for Investors</span>
	</div>
	<div id="userTools">
		<span id="welcome">Welcome!</span>
		<ul id="premium" class="dropMenu">
          <li class="topLevel"><a href="/web/20100104083858/http://www.fool.com/shop/newsletters/index.aspx" class="qsAdd qs-source-ipesittph0000001"><span><span>Premium Advice</span></span></a><ul>
              <li class="info subhead"><strong>My Services</strong></li>
              <li class="info">None</li>
              <li class="info subhead"><strong>Other Services</strong></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/11/">Champion Funds</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/40/">Duke Street</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/25/">Global Gains</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/04/">Hidden Gems</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/08/">Income Investor</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/14/">Inside Value</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/30/?aid=3249">Million Dollar Portfolio</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/50/">Motley Fool Options</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/37/?aid=3024">Motley Fool Pro</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/26/">Pay Dirt</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/36/index.aspx?cid=1455">Ready-Made Millionaire</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/15/">Rule Breakers</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="/web/20100104083858/http://newsletters.fool.com/13/">Rule Your Retirement</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002 last" href="/web/20100104083858/http://newsletters.fool.com/18/">Stock Advisor</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002 last" href="/web/20100104083858/http://www.fool.com/landing/card/decide.asp">*Get a Fool Credit Card</a></li>
            </ul>
          </li>
        </ul>
		
		
		<span id="Help"><a class="qsAdd qs-source-ihesittph0000001" href="/web/20100104083858/http://www.fool.com/help/index.htm">Help</a></span>
		<span id="join"><a class="qsAdd qs-source-ijnsittph0000001" href="/web/20100104083858/http://www.fool.com/Landing/TMF/Registration.aspx">Join Now</a></span>
		<span>or</span>
		<span id="login"><a class="qsAdd qs-source-ilgsittph0000001" href="/web/20100104083858/https://www.fool.com/secure/login.aspx">Login</a></span>
	</div>
</div>
  </div><script type="text/javascript">Fool.Util.PseudoClass.hover('#tophatWrap li.topLevel');</script></div><div id="topnav"><div class="grid">
	<!--Version A - DO NOT REMOVE THIS TOPNAV COMMENT!-->
	<div id="logo"><a class="&#xA;&#x9;&#x9;&#x9;&#x9;&#x9;qsAdd qs-source-illsitima0000001&#xA;&#x9;&#x9;&#x9;&#x9;" href="/web/20100104083858/http://www.fool.com/">The Motley Fool
			</a></div>
	<form id="searchForm" method="get" action="/web/20100104083858/http://www.fool.com/search/solr.aspx"><fieldset id="search"><input class="query" value="Enter Keywords or Ticker" type="text" name="q" maxlength="100" /><input type="hidden" name="source" value="ignsittn0000001" /><input id="commandSearch" class="btn doSearch" type="submit" /></fieldset></form>
	<div id="indices"><div class="round"><table cellspacing="0" cellpadding="0"><thead><tr class="updated"><td colspan="5">Updated: 12/31/2009 4:04 PM</td><td>Sponsored by:</td></tr></thead><tbody><tr class="dji"><td class="image neg"><img src="/web/20100104083858im_/http://g.fool.com/common/img/topNav/down.gif?v=62615b" /></td><td class="index"><a class="unvisit qsAdd qs-source-ihpdspmki0000001" href="/web/20100104083858/http://caps.fool.com/ticker/%5EDJI.aspx">DOW</a></td><td class="value"><div class="shieldContainer">10428.05</div></td><td class="change neg"><div class="shieldContainer">-120.46</div></td><td class="percentChange neg"><div class="shieldContainer">-1.14%</div></td></tr><tr class="gspc"><td class="image neg"><img src="/web/20100104083858im_/http://g.fool.com/common/img/topNav/down.gif?v=62615b" /></td><td class="index"><a class="unvisit qsAdd qs-source-ihpdspmki0000001" href="/web/20100104083858/http://caps.fool.com/ticker/%5EGSPC.aspx">S&amp;P 500</a></td><td class="value"><div class="shieldContainer">1115.10</div></td><td class="change neg"><div class="shieldContainer">-11.32</div></td><td class="percentChange neg"><div class="shieldContainer">-1.01%</div></td></tr><tr class="ixic last"><td class="image neg"><img src="/web/20100104083858im_/http://g.fool.com/common/img/topNav/down.gif?v=62615b" /></td><td class="index"><a class="unvisit qsAdd qs-source-ihpdspmki0000001" href="/web/20100104083858/http://caps.fool.com/ticker/%5EIXIC.aspx">NASD</a></td><td class="value"><div class="shieldContainer">2269.15</div></td><td class="change neg"><div class="shieldContainer">-22.13</div></td><td class="percentChange neg"><div class="shieldContainer">-0.97%</div></td></tr></tbody></table><div class="ad-88x30">
		<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=88x33;ptile=1;ord=42146715"><!--ad--></script><noscript><a rel="nofollow" target="_blank" href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=88x33;ptile=0;ord=42146715"><img border="0" alt="" src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=88x33;ptile=0;ord=42146715" /></a></noscript>
	</div></div><script type="text/javascript">
					var Indices = new Usmf.Indices(10);
				</script></div>
	<div id="menu" class="grid clearfix"><div class="column span-25"><ul class="clearfix">
		<li class="qsAdd qs-source-iflsittph0000001"><a href="/web/20100104083858/http://www.fool.com/" class="qsAdd qs-source-iflsittph0000001"><span>Home</span></a>
			<ul>
				<li class="qsAdd qs-source-ifltnvsnv0000001 foolwatch"><a href="/web/20100104083858/http://www.fool.com/foolwatch/foolwatch.aspx" class="qsAdd qs-source-ifltnvsnv0000001 foolwatch">All Fool Headlines</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/foolanthropy/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Foolanthropy</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/press/about.htm" class="last qsAdd qs-source-ifltnvsnv0000001">About The Motley Fool</a></li>
			</ul>
		</li>
		<li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/web/20100104083858/http://www.fool.com/how-to-invest/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>How To Invest</span></a>
			<ul>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/how-to-invest/thirteen-steps/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">13 Steps</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/how-to-invest/broker/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Find a Broker</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://wiki.fool.com/" class="qsAdd qs-source-ifltnvsnv0000001">Investing Wiki</a></li>		
				<li class=" last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/how-to-invest/personal-finance/index.aspx" class=" last qsAdd qs-source-ifltnvsnv0000001">Personal Finance</a></li>
			</ul>
		</li>
		<li class="qsAdd qs-source-ifltnvpnv0000001 on"><a href="/web/20100104083858/http://www.fool.com/investing/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>Investing Commentary</span></a>
			<ul>
				<li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/basics/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001">Basics</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/etf/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">ETFs</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/options/options-a-foolish-introduction.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Options</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/small-cap/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Small-Cap</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/dividends-income/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Dividends &amp; Income</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/high-growth/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">High Growth</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/value/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Value</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/mutualfunds/mutualfunds.htm" class="qsAdd qs-source-ifltnvsnv0000001">Mutual Funds</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/investing/international/index.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">International</a></li>
			</ul>
		</li>
		<li class="capsTab qsAdd qs-source-ifltnvpnv0000001"><a href="/web/20100104083858/http://caps.fool.com/index.aspx" class="capsTab qsAdd qs-source-ifltnvpnv0000001"><span>CAPS Community</span></a>
			<ul>
				<li class="capsHome qsAdd qs-source-icasitlnk0000006"><a href="/web/20100104083858/http://caps.fool.com/" class="capsHome qsAdd qs-source-icasitlnk0000006">CAPS Home</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/" class="qsAdd qs-source-ifltnvsnv0000001">CAPS Home</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/MyPlayer.aspx" class="qsAdd qs-source-ifltnvsnv0000001">My CAPS</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/TickerRankings.aspx?filter=7&sortcol=38&sortdir=1" class="qsAdd qs-source-ifltnvsnv0000001">Stocks</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/Screener.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Screener</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/PlayerRankings.aspx?filter=20&sortcol=5&sortdir=1" class="qsAdd qs-source-ifltnvsnv0000001">Members</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/Blogs/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Blogs</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/Stats.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Top Tens</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/TagRankings.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Tags</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/Contests.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Contests</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/FeedBack.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Contact Us</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://caps.fool.com/Help.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">Help</a></li>
			</ul>
		</li>
		<li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/web/20100104083858/http://www.fool.com/retirement/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>Retirement Planning</span></a>
			<ul>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/retirement/general/how-to-retire-in-style.aspx" class="qsAdd qs-source-ifltnvsnv0000001">13 Retirement Steps</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/retirement/ira/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">IRAs</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/retirement/401k/401kintro-is-your-retirement-plan-foolish.aspx" class="qsAdd qs-source-ifltnvsnv0000001">401(k)s, Etc.</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://www.fool.com/retirement/assetallocation/introduction-to-asset-allocation.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">Asset Allocation</a></li>
			</ul>
		</li>	
		<li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/web/20100104083858/http://boards.fool.com/" class="qsAdd qs-source-ifltnvpnv0000001"><span>Boards</span></a>
			<ul>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://boards.fool.com/BestOf.asp" class="qsAdd qs-source-ifltnvsnv0000001">Best Of</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://boards.fool.com/favoriteboards.asp" class="qsAdd qs-source-ifltnvsnv0000001">Favorites &amp; Replies</a></li>
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://boards.fool.com/EditFavoriteBoards.asp" class="qsAdd qs-source-ifltnvsnv0000001">Customize</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/web/20100104083858/http://boards.fool.com/request.asp" class="last qsAdd qs-source-ifltnvsnv0000001">Start a New Board</a></li>
			</ul>
		</li>
		<li class="premium qsAdd qs-source-ipesittph0000001"><a href="/web/20100104083858/http://www.fool.com/shop/newsletters/index.aspx" class="premium qsAdd qs-source-ipesittph0000001"><span>Premium Advice</span></a>
			<ul>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/18/index.aspx" class="qsAdd qs-source-ipesittph0000002">Stock Advisor</a></li>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/04/index.aspx" class="qsAdd qs-source-ipesittph0000002">Hidden Gems</a></li>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/15/index.aspx" class="qsAdd qs-source-ipesittph0000002">Rule Breakers</a></li>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/08/index.aspx" class="qsAdd qs-source-ipesittph0000002">Income Investor</a></li>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/30/index.aspx?aid=3249" class="qsAdd qs-source-ipesittph0000002">Million Dollar Portfolio</a></li>
				<li class="qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/37/index.aspx" class="qsAdd qs-source-ipesittph0000002">Motley Fool PRO</a></li>
				<li class="last qsAdd qs-source-ipesittph0000002"><a href="/web/20100104083858/http://newsletters.fool.com/25/index.aspx" class="last qsAdd qs-source-ipesittph0000002">Global Gains</a></li>
			</ul>
		</li>
	</ul></div></div>
	<img width="0" height="0" class="vs-tracking-px" src="/web/20100104083858im_/http://www.fool.com/tracking/vs/vs_track.gif?_rnd=43346586&actual_url=http%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2009%2f12%2f31%2f2010-fda-decisions-to-watch.aspx&articletype=collection548&author=Brian+Orelli&CellID=0&CriteriaForCln=VocabularyCriteriaForClean&headline=2010+FDA+Decisions+to+Watch&lemoraAdWidth=90&log=1&LogicViewEcap=UserIsNotRegisteredForArticleEcap&lvButterFatAd=AlwaysTrueRenderCriteria&referrer=http%3a%2f%2fwww.fool.com%2f&sector=Pharmaceuticals&segment=default&site=usmf.inv.investing&storytype=Commentary&TestID=CLN%3a004&uid=1347602312&url=http%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2009%2f12%2f31%2f2010-fda-decisions-to-watch.aspx&usmfClean=DoesNotOwnStockAdvisor&usmfRedirectCriteria=AlwaysTrue&zone=articles" />
</div></div><script type="text/javascript">	var topNav = new Usmf.Tabs('menu'); topNav.insertSubnavElement('foolwatch', 'Motley Fool Funds', 'You are leaving Fool.com, operated by The Motley Fool, LLC.  Would you like to continue to FoolFunds.com, operated by Motley Fool Asset Management, LLC?', '/web/20100104083858/http://www.foolfunds.com'); new Fool.Util.SearchBox('searchForm');</script>
	</div>








		
	<div id="mid">
		<div class="grid">
			
    <form name="aspnetForm" method="post" action="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" id="aspnetForm">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKMTkwMTQ1Mzc5M2RkV13kkpU8Ff1/dJefbwVosym2aXA=" />

<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWAgLN9ZfcCwK12OHqCeGnrrlyywlhLWny1DMMiF0s5+BK" />
	    <div id="flash">
		    
		    
<div id="promoAndLeaderboard" class="clearfix">
    <div class="leaderboard ad-728x90">
        <script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;dcopt=ist;pos=top;seg=default;src=;sz=728x90;ptile=3;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;dcopt=ist;pos=top;seg=default;src=;sz=728x90;ptile=3;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;dcopt=ist;pos=top;seg=default;src=;sz=728x90;ptile=3;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
    </div>
    <div class="promo">
        <script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=237x90;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=237x90;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=237x90;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
    </div>
</div>
		    
		    
	    </div>

	    <div id="layout" class="bigBox round clearfix">
		    
		    
	<!-- ArticlesContent.Master -->
	
	
	<div id="primary" class="column collection548">
		<div id="content" class="hentry">

			
			<!--googleon:all-->
			<h1>2010 FDA Decisions to Watch</h1>

			
			<p class="articleMeta">
				<span class="vcard byline">By
				Brian Orelli
				</span><br />
				<span class="dateline">December 31, 2009</span>
				|
				<span class="comments"><a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#commentsBoxAnchor">Comments (6)
				</a></span>
			</p>

			<div class="entry-content">
				<div id="recModule">
					
					
	<div class="recommendCtl">
		<div class="recWrap" id="numRecsWrapper" 
			title="8 members have recommended this article">
			<p>Recs</p>
			<h3>
				<span>
					8
				</span>
			</h3>
		</div>
		
	</div>

				</div>
				
				
<ul id="toolBox">
	
		<li class="email">
			<a href="/web/20100104083858/http://www.fool.com/server/FoolEMail.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx"><img src="/web/20100104083858im_/http://g.fool.com/img/ShareThis/email.gif" /></a> <a href="/web/20100104083858/http://www.fool.com/server/FoolEMail.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx">Email</a>
		</li>
	
	
	
		<li class="share">
			<span id="shareThisWrapper">
				<a href="javascript:void(0);" class="share"><img src="/web/20100104083858im_/http://g.fool.com/img/ShareThis/share.gif" /></a> <a class="share" href="javascript:void(0);">Share</a>
			</span>
		</li>
	
	
	<li class="print">
		<a href="/web/20100104083858/http://www.fool.com/server/FoolPrint.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx"><img src="/web/20100104083858im_/http://g.fool.com/img/ShareThis/print.gif" /></a> <a href="/web/20100104083858/http://www.fool.com/server/FoolPrint.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx">Print</a>
	</li>
	
	
	
</ul>


	<script src="/web/20100104083858js_/http://w.sharethis.com/widget/?tabs=web%2Cemail%2Cpost&charset=utf-8&onmouseover=false&style=default&publisher=af67b56a-157c-4f97-8dc3-18f695803f58&embeds=true&headerbg=%23F4F7FB&inactivebg=%23f1f1f1&inactivefg=%23666666&linkfg=%234C91E6" type="text/javascript"></script>
	<script language="javascript" type="text/javascript">
		//Create your sharelet with desired properties and set button element to false
		var object = SHARETHIS.addEntry({
			
			title: "2010 FDA Decisions to Watch"
			
			,summary: "It's a pivotal year for these drugmakers."
			
		},
		{ button: false });
		//Tie customized button to ShareThis button functionality.
		var element = document.getElementById("shareThisWrapper");
		object.attachButton(element);
	</script>

				
				
				
				
				
			    

					
				
				
				    		
						            
		<?xml version="1.0" encoding="utf-16"?><div class="inlineArticleBox targetedPromotion unvisit" id="saTargetedPromotion">
<h4 style="margin:0;">Disney Buys Marvel!</h4>
<a class="qsAdd qs-source-isasitlnk3500085" href="/web/20100104083858/http://www.fool.com/shop/newsletters/18/index.htm"><img border="none" height="120" src="/web/20100104083858im_/http://g.fool.com/img/article/cln/dg-phone1.jpg" style="float: right;" width="50" /></a>
<p style="margin-top: 5px;">
	David Gardner called it. Heâ€™s up 1,334%! See what Davidâ€™s recommending that you buy NEXT. 
</p>
<ul>
	<li>
		<a class="qsAdd qs-source-isasitlnk3500085" href="/web/20100104083858/http://www.fool.com/shop/newsletters/18/index.htm" title="Learn more">
			Click Here Now
		</a>
	</li>
</ul></div>
	
					            
				    

				<p>Being a drug-company <a class="wikiTerm qsAdd qs-source-ihlsitlnk0000001" href="/web/20100104083858/http://wiki.fool.com/Shareholder" title="Get the definition on The Motley Fool Investing Wiki">shareholder</a> before the Food and Drug Administration makes decisions about those companies' drugs can be scary, but it can also lead to <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2007/05/17/start-making-67000-today.aspx">spectacular returns</a>. If you have the <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/11/12/do-you-have-the-guts-to-buy.aspx">guts to buy</a>, here are a few drug companies hoping for those kinds of returns next year.</p>
<p>
  <strong>Exubera 2.0?</strong>
  <br />The biggest hurdle for <strong>Mannkind</strong>'s   <span class="ticker">(Nasdaq: <a href="/web/20100104083858/http://caps.fool.com/Ticker/MNKD.aspx" class="qsAdd qs-source-isssitthv0000001">MNKD</a>)</span> inhaled insulin, Afresa, probably won't be getting past the <a class="wikiTerm qsAdd qs-source-ihlsitlnk0000001" href="/web/20100104083858/http://wiki.fool.com/FDA" title="Get the definition on The Motley Fool Investing Wiki">FDA</a> near its <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2008/08/14/a-potentially-painless-pdufa-date.aspx">PDUFA</a> date of Jan 16. Insulin is a pretty basic drug, and Afresa seems to have a better profile than other options; unlike current offerings, it mimics natural insulin spikes seen in non-diabetics after they eat.</p>
<p>Instead, Mannkind's biggest obstacle will be on the marketing front, keeping from following in the footsteps of <strong>Pfizer</strong>   <span class="ticker">(NYSE: <a href="/web/20100104083858/http://caps.fool.com/Ticker/PFE.aspx" class="qsAdd qs-source-isssitthv0000001">PFE</a>)</span> and <strong>Nektar Therapeutics</strong>' inhaled insulin, Exubera. Not too many doctors were exuberant about Exubera; the drug/device registered a measly $12 million in sales during its first nine months on the market before Pfizer gave up and handed the drug back to Nektar.</p>
<p>Afresa is smaller than Exubera, and Mannkind is working on an even smaller device whose size will be a selling point. Ultimately, though, it will come down to whether doctors are interested in trying out a new product when the current offerings work well enough and whether patients request a needle-free alternative.</p>
<p>Mannkind may be able to get some traction, but I expect a slow uptake.</p>
<p>
  <strong>678 fewer injections</strong>
  <br />
  <strong>Amylin Pharmaceuticals</strong>   <span class="ticker">(Nasdaq: <a href="/web/20100104083858/http://caps.fool.com/Ticker/AMLN.aspx" class="qsAdd qs-source-isssitthv0000001">AMLN</a>)</span> and <strong>Eli Lilly</strong>'s   <span class="ticker">(NYSE: <a href="/web/20100104083858/http://caps.fool.com/Ticker/LLY.aspx" class="qsAdd qs-source-isssitthv0000001">LLY</a>)</span> Byetta is a great drug. It controls diabetics' glucose well, keeping them from having to go onto insulin. It even has an added benefit of causing <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/02/20/the-skinny-on-diabetes-drugs.aspx">weight loss</a>.</p>
<p>The only problem is that the drug has to be injected twice a day. That's fairly burdensome compared with popping pills like <strong>Merck</strong>'s   <span class="ticker">(NYSE: <a href="/web/20100104083858/http://caps.fool.com/Ticker/MRK.aspx" class="qsAdd qs-source-isssitthv0000001">MRK</a>)</span> Januvia, and sales have suffered, reaching only $679 million last year and falling slightly through the first three quarters of this year as some worries of <a href="/web/20100104083858/http://www.fool.com/investing/general/2008/08/27/amylin-answers-investors-panic.aspx">pancreatitis</a> have arisen.</p>
<p>The duo's solution is a once-weekly formula of Byetta using <strong>Alkermes</strong>' extended-release technology. The decreased injections should increase sales, but first they'll have to get past the FDA in March. The efficacy data looked good -- it <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/03/31/amylin-smacks-down-the-competition.aspx">beat</a> Januvia and Takeda's Actos in head-to-head trials -- but the FDA may be leery of an approval because of the side-effect issue. <strong>Novo Nordisk</strong>'s once-daily liraglutide, which is in the same class, has been waiting for an FDA approval since last March.</p>
<p>Once-weekly Byetta should be approved, but don't expect a speedy FDA decision.</p>
<p>
  <strong>2 years in the making</strong>
  <br />After the FDA's <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2007/05/09/diagnosing-dendreon-postmortem.aspx">somewhat shocking</a> denial of <strong>Dendreon</strong>'s   <span class="ticker">(Nasdaq: <a href="/web/20100104083858/http://caps.fool.com/Ticker/DNDN.aspx" class="qsAdd qs-source-isssitthv0000001">DNDN</a>)</span> prostate-cancer treatment Provenge in May of 2007, the company will have another date with the FDA on May 1 of next year.</p>
<p>The data the FDA previously requested <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/04/29/2-lessons-from-dendreon.aspx">turned out positive</a>, so an approval seems more likely than not. The biggest risk is that the FDA finds something wrong on the manufacturing side of things. The treatment takes immune cells from a patient and trains them to become cancer-fighting machines before putting them back into the patient. The FDA needs to be certain that Dendreon can accurately repeat the process.</p>
<p>Here's hoping that Dendreon doesn't end up sending out another mayday to investors on May Day.</p>
<p>
  <strong>Potential obesity-drug approvals: size XXXL</strong>
  <br />2010 could see the FDA weighing in on three obesity drugs. <strong>Arena Pharmaceuticals</strong> and <strong>VIVUS</strong>   <span class="ticker">(Nasdaq: <a href="/web/20100104083858/http://caps.fool.com/Ticker/VVUS.aspx" class="qsAdd qs-source-isssitthv0000001">VVUS</a>)</span> both submitted their applications to the FDA this month, and <strong>Orexigen Therapeutics</strong> expects to file in the first half of next year.</p>
<p>Of the three, VIVUS' Qnexa probably has the <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/09/09/weight-down-stock-price-up-really-up.aspx">best weight-loss data</a>, but Arena's Lorcaserin may have the <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/09/18/up-down-up-is-this-stock-a-home-run-or-not.aspx">best safety profile</a>. The latter is important, since diet and exercise work pretty well as treatments for obesity and the agency is likely to be very <a href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/11/23/the-side-effect-of-developing-obesity-drugs.aspx">safety conscious</a>. An approval for any or all of the drugs isn't a slam dunk, but considering the large market, the risk could be worth the reward.</p>
<p>
  <strong>Usual disclosures apply</strong>
  <br />Keep in mind that the FDA sets up <a href="/web/20100104083858/http://wiki.fool.com/PDUFA">PDUFA</a> dates, but they're not a deadline that the agency is required to meet. Trying to day-trade around the <a class="wikiTerm qsAdd qs-source-ihlsitlnk0000001" href="/web/20100104083858/http://wiki.fool.com/PDUFA" title="Get the definition on The Motley Fool Investing Wiki">PDUFA</a> date can be dangerous to your portfolio. A much better strategy is to think <a href="/web/20100104083858/http://www.fool.com/investing/general/2008/02/01/the-greatest-secret-of-all.aspx">longer-term</a>. Find a company you like at a price you can live with, and don't worry about any delays the FDA may throw at your investment.</p>
<p>
  <em>Any other FDA decisions you're looking forward to in the new year? Let us know in the comment box below.</em>
</p>
				
				<!-- Start Poll-specific article -->
        		
        		<!-- End Poll-specific article -->
				
				
				
					
					
			  					<script src="/web/20100104083858js_/http://g.fool.com/Common/js/Controls/Landing/Ecap.min.js?v=62615b" type="text/javascript"></script>

<div id="" class="ecap ">
	<h4>â€œThe most exciting development in my lifetime!â€ -- 15 years ago, Motley Fool founder David Gardner uncovered a secret that changed how heâ€™d invest forever. It can make you money in 2010 â€“ no matter whether the market is up, down, and dead flat. To learn more, enter your email address now!</h4>

	
		<input type="hidden" name="campaignId" value="3333" />
		<input type="hidden" name="source" value="iecsitewd0000001" />
		<input type="hidden" name="messageSuccess" value="Thank you for your interest in Motley Fool PRO. We will notify you the instant we begin enrolling new members in January. Meanwhile, download Jeff Fischerâ€™s premium report â€œOptions 401 â€“ How to Protect Your Gains in an Uncertain Marketâ€ â€“ itâ€™s FREE, &lt;a href=&quot;http://g.fool.com/art/download/37/sp0110Options401.pdf&quot;&gt;click here!&lt;/a&gt;" />
		<input type="hidden" name="returnUrl" value="http%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2009%2f12%2f31%2f2010-fda-decisions-to-watch.aspx" />
		<span class="ecapFields">
				<input type="text"  class="ecapInput" maxlength="50" name="emailAddress" value="Enter Email Address" />
				<input type="submit" name="ctl01$ctl00$ctl00$ctl00$ctl00$ctl00$cphContent$cphContent$cphContent$ArticleMasterPlaceHolder$LogicViewEcap$LogicViewCellUnregistered$ctl00$ECap$btnSubmit" value="Click Here, It's Free" id="ctl01_ctl00_ctl00_ctl00_ctl00_ctl00_cphContent_cphContent_cphContent_ArticleMasterPlaceHolder_LogicViewEcap_LogicViewCellUnregistered_ctl00_ECap_btnSubmit" class="ecapButton" />
		</span>

		<span class="ecapValidation"></span>
	
</div>



							 <div class='newFooter'><p><em>Pfizer is a</em> <a href="/web/20100104083858/http://www.fool.com/shop/newsletters/14/index.htm?source=iivedilnk825093">Motley Fool Inside Value</a> <em>choice. Novo Nordisk is a</em> <a href="/web/20100104083858/http://www.fool.com/shop/newsletters/25/index.htm?source=iggedilnk2550001">Motley Fool Global Gains</a> <em>selection.</em> <em>Try any of our Foolish newsletter services <a href="/web/20100104083858/http://www.fool.com/shop/newsletters/index.htm?source=isiedilnk018048">free for 30 days</a>.</em></p><p><em>Fool contributor</em> <a href="/web/20100104083858/http://my.fool.com/profile/TMFBiologyFool/info.aspx"><em>Brian Orelli</em></a><em>, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a</em> <a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=about02"><em>disclosure policy</em></a>.</p></div>
			</div><!-- /entry-content -->

		</div><!-- /content -->
        
		<div id="articleTools">
			<p id="recModuleBottom">
				<a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#commentsBoxAnchor">Read/Post Comments (6)</a>
				<span> | </span>
				


	<span class="recInline">
		Recommended 8 Times
	</span>

			</p>
			<ul class="toolBox">
				<li><a href="/web/20100104083858/http://www.fool.com/server/FoolEMail.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" class="email">Email</a></li>
				<li><a href="/web/20100104083858/http://www.fool.com/server/FoolPrint.asp?File=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" class="print">Print</a></li>
				<li><a href="/web/20100104083858/http://www.fool.com/Help/Index.htm?display=EmailNews&p=/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" class="feedback">Feedback</a></li>
				<li><a href="/web/20100104083858/http://digg.com/submit?phase=2&url=http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx" class="digg">Digg</a></li>
				<li><a href="/web/20100104083858/http://del.icio.us/post" onclick="window.open('/web/20100104083858/http://del.icio.us/post?v=4&amp;partner=fool&amp;noui&amp;jump=close&amp;url='+encodeURIComponent(location.href)+'&amp;title='+encodeURIComponent(document.title),'delicious','toolbar=no,width=700,height=400'); return false;" class="delicious">Delicious</a></li>
				<li><a href="/web/20100104083858/http://feeds.fool.com/usmf/foolwatch" class="rss">RSS</a></li>
			</ul>
		</div><!-- /articleTools -->

		<div class="promoboxAd">
		    
                  <script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
                
		</div>

		<div class="component" id="articleCommentsAjaxContainer">
			
<script type="text/javascript" src="/web/20100104083858js_/http://www.fool.com/js/ArticleComments.js"></script>

<input name="ArticleID" id="ArticleID" type="hidden" value="1075732"/> 
<div id="comments">
<a name="commentsBoxAnchor" id="commentsBoxAnchor"></a>
<h3 class="boxTop">Comments from our Foolish Readers</h3>
<p class="intro"><strong>Help us keep this a respectfully Foolish area!</strong> This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above.  Help us keep it clean and safe.  If you believe a comment is abusive or otherwise violates our <a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=newuser02">Fool's Rules</a>, please report it via the <img src="/web/20100104083858im_/http://www.fool.com/art/article/icn_comment-redhand.gif" alt="Report this Comment" /> <strong>Report this Comment</strong> icon found on every comment.</p>
<div id="ajaxPosts">
	
		<ul id="commentsList" class="truncated">
			
					<li id="comment319517">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On December 31, 2009,
								at 2:52 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=285270"><strong>norman1066</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>Thanks for an interesting article,</p><p>Afresa will have no trouble outselling Exubera. Pfizer's drug was more costly than injectable insulin yet was neither more effective nor safer. On the other hand Afresa works just as well, doesn't cause weight gain, and is measurably SAFER.</p><p>This last point is important as it will potentially allow physicians to prescribe Afresa earlier in type 2 diabetics disease progression. It is possible that Afresa could become the first line therapy (not in 2010 but possibly in a couple of years). If that occurs Mannkind will have a mega drug on its hands.</p><p>The big hurdle for Mannkind appears to be getting a big pharma partner for the drug as MNKD isn't your typical bio start-up eager to take any bone thrown its way. With Al Mann's deep pockets they have chosen to blaze their own trail right through to FDA approval. It should be entertaining to see what deal they eventually strike and how the street perceives it.</p></div>
                        
                </li>
				
					<li id="comment319543">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On December 31, 2009,
								at 3:33 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=364578354"><strong>goyocafe</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>&quot;...when the current offerings work well enough...&quot;</p><p>Comments like this only demonstrate a lack of appreciation for diabetes treatments that exist today. If this were true, why then is there such a huge untapped market for new treatments for this terrifying disease?</p></div>
                        
                </li>
				
					<li id="comment319572">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On December 31, 2009,
								at 4:34 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=1346891630"><strong>pharmagenius</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>Why no mention of GENEREX's ORAL-LYN? Their oral insulin product is coming up for FDA approval in 2010. Its currently in Phase III trials in Canada and the U.S. They already have FDA approval for emergency use and ORAL-LYN is already in use in several countries. </p></div>
                        
                </li>
				
					<li id="comment319582">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On December 31, 2009,
								at 5:03 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=215200129"><strong>JPG101</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>Generex doesn't actually sell insulin if you look at their balance sheet.  They are in trouble in India. Management pays itself very well for a small company with no partnerships or institutional buy in. </p><p>I think this is a scam company that will go broke with time. The individual small investors will get seriously burnt with this company.</p></div>
                        
                </li>
				
					<li id="comment319770">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On January 01, 2010,
								at 5:03 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=1106040788"><strong>AlexKalman</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>FOOL, MISSES PHASE III FOR SOME CANCERS?</p><p>Next Dendreon? Novelos' CEO Eyeing &quot;Revolutionary&quot; Phase III Results</p><p>Written by M.E.Garza </p><p>Wednesday, 16 December 2009 00:00 </p><p>&quot;What's interesting about Novelos is that we're in a Pivotal Phase III trial for lung cancer under both SPA and Fast Track for our NOV-002 lead compound,&quot; explains Novelos Therapeutics' (OTC: NVLT) Chief Executive Officer, Harry S. Palmin.</p><p>The study, a randomized, open-label, Phase 3 Trial of NOV-002 in Combination with Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin alone for the treatment of advanced non-small cell lung cancer is being conducted under the FDA's Special Protocol Assessment. It blinds Novelos from seeing any results as it progresses. </p><p>In other words, there is no interim analysis. There is only &quot;one look&quot; and that look occurs once 725 deaths take place during the trial.</p><p>&quot;These patients with a median survival of eight to ten months unfortunately die pretty quickly,&quot; explains Novelos Therapeutics' Chief Executive Officer, Harry S. Palmin. &quot;One year survival, which is another way to look at this, is just about 40%.&quot;</p><p>The pivotal study itself began more than three years ago, in November of 2006. By March of 2008, the enrollment target of patients had been reached and now, over a year and a half later, the 725th event has not yet occurred. </p><p>It's become pretty obvious, even to the most casual observer, that the patients involved in the trial are living longer than expected and that, in fact, is one of the reasons why Wall Street has begun to take more interest in the company and the study. Originally, most observers, including insiders at the company, expected that the trial might reach a conclusion some time during the middle of this year. </p><p>&quot;It's a very unique value proposition,&quot; says Palmin. &quot;If you think of Avastin, Roche's drug, it's the only drug in non-small cell lung cancer, first line treatment that showed a survival advantage. They showed a two month survival advantage, 12.3 months versus 10.3, but the drug has severe toxicities associated with it on top of the chemotherapy toxicities and it's very expensive. It's also only available to very few lung cancer patients because the histology it works for is non-squamous. </p><p>&quot;The point that I'm trying to make is that given our current statistical projections, because our trial is going late, if we assume that the control group does in fact what it's supposed to, around a ten month median survival, and there's historical data on some four-thousand patients with advanced stage lung cancer that have taken our type of chemotherapy (paclitaxel/carboplatin [standard of care in the U.S.]), then we should be on track to achieve or possibly even exceed our possible twelve and a half month median survival target.</p><p>&quot;By way of background, we started the pivotal Phase III on lung cancer on the back of three Phase II's,&quot; explains Palmin. &quot;Same patient population and in two of the trials that were done in Russia, we saw dramatic survival advantages, better anti-tumor effects and in the United States, we saw doubling response rates and better toleration of chemotherapy. So there are three lung cancer trials that were the basis for the pivotal Phase III. We, of course, have applicability to other indications because we're not tumor specific and we're not chemotherapy specific.&quot;</p><p>That is an important point that has not gone unnoticed. This year, Perdue Pharma has invested over $19 million dollars in Novelos. The company itself, since going public over 5 years ago, has raised over $70 million dollars.</p><p>&quot;We had good data out of Russia in non-small cell lung and it is the number one cancer killer, currently; late stage lung cancer,&quot; says Palmin. &quot;There are north of two-hundred thousand new patients each year and more than one hundred and sixty thousand deaths and it's a huge market. Just lung cancer is north of a $3.5 billion dollar market. </p><p>&quot;Since we have applicability, really, to all solid tumors, in Russia the drug is already approved for general use with chemotherapy. Here in the United States, we've had two positive Phase II results in ovarian and breast cancer. Channel 7 in Miami recently profiled a breast cancer patient that was in our Phase II breast cancer trial and went into complete remission. No signs of cancer. That's based on publicly available information where we've had forty percent of the patients have had no sign of their cancer after treatment of chemo and our drug.</p><p>&quot;In addition, the patients that take our drug with the chemotherapy have a much better quality of life while under that treatment, versus being on chemo alone. Plus, very importantly, there is the efficacy improvement. That makes this a very different approach to the treatment of cancer.&quot;</p></div>
                        
                </li>
				
					<li id="comment320263">
						<div class="commentHead">
							<h6>
							  <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
							  On January 03, 2010,
								at 9:56 PM, 
								<a href="/web/20100104083858/http://boards.fool.com/Profile.asp?uid=129840865"><strong>larssral</strong></a> wrote:
							</h6>
						</div>
						<div class="commentPost"><p>Chelsea Therapeutics (CHTP) is wrapping a phase three trial for Droxidopa (indication for orthostatic hypotension) which it successfully petitioned changes to the study's endpoint.  </p><p>They were asked to conduct an additional trial, which should put them in place to submit an NDA by the end of 2010, if not sooner.  </p></div>
                        
                </li>
				
		</ul>
	    <a name="newCommentAnchor" id="newCommentAnchor"></a>
		<h5>Add your comment.</h5>
	
	
	
</div>

	



	

	<div id="newComment" class="addNew commentTools" style="display:none">
		<p id="P1">
			Your Fool username<!-- of <strong>insert username here</strong>--> will be displayed with your comment.<br /><br />
			Please be respectful with your comments. Review our <a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=newuser02">Fool's Rules</a>.
		</p>
		<textarea name="txtBody" rows="12" cols="30" id="txtBody" class="textbox" onclick="Fool.Authenticate()" ></textarea>

		<div class="buttons">
			<input type="button" id="btnSave" class="button" value="Post Your Comment" onclick="ArticleComments.doSave()" /> 
		</div>

	</div> 

<script type="text/javascript">
	ArticleComments.showTools();
</script>
<noscript>
	<div id="jsWarning">
		<p>Javascript is required to comment on Fool articles.</p>
	</div>
</noscript>


</div>






















		</div>
		<!--googleoff:all-->
		
<div class="compareBrokersAds">
	<h3 class="boxTop"><a href="/web/20100104083858/http://www.fool.com/dbc/tables/compare.htm?source=ifldbcdbx0000002">Compare Brokers</a></h3>
	<div class="compareBrokersBox">
		<h6>TD AMERITRADE</h6>	
		<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		<a href="/web/20100104083858/http://www.fool.com/dbc/tables/tdameritrade.htm?source=ipt3stdbx0000001" class="moreinfo">more info</a>
	</div>
	<div class="compareBrokersBox">
		<h6>ShareBuilder</h6>	
		<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		<a href="/web/20100104083858/http://www.fool.com/dbc/tables/sharebuilder.htm?source=iptshbdbx0000001" class="moreinfo">more info</a>
	</div>
	<div class="compareBrokersBox">
		<h6>Power E*Trade</h6>	
		<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		<br /><a href="/web/20100104083858/http://www.fool.com/dbc/tables/etrade.htm?source=iptetrdbx0000001" class="moreinfo">more info</a>
	</div>
	<div class="compareBrokersBox">
		<h6>Scottrade</h6>
			<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		<a href="/web/20100104083858/http://www.fool.com/dbc/tables/scottrade.htm?source=iflscolnk0000001" class="moreinfo">more info</a>
	</div>
	<a href="/web/20100104083858/http://www.fool.com/dbc/disclosure.htm?source=compare" class="disclosure">Fool Disclosure</a>
</div>

		<div class="sponsoredLinksAd">
			<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=splinks;seg=default;src=;sz=1x1;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=splinks;seg=default;src=;sz=1x1;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=splinks;seg=default;src=;sz=1x1;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		</div>

		<p class="debug">DocumentId: 1075732, ~/Articles/ArticleHandler.aspx, 1/4/2010 3:38:58 AM</p>
		<!-- do not remove this comment - articlescontent -->
		
		
		

	</div><!-- /primary -->

	

<fieldset id="foolcop">

	<h3>Report This Comment</h3>

	<p>
		Use this area to report a comment that you believe 
		is in violation of the community guidelines. Our 
		team will review the entry and take any appropriate 
		action.
	</p>

	<input type="hidden" name="whichComment" id="whichComment" value="" />
	<input type="hidden" name="commentContent" id="commentContent" value="" />

	<textarea name="reporterNote" id="reporterNote" rows="4" cols="18"></textarea>

	<div class="buttons">
		<input class="button" name="reportToFoolCop" id="reportToFoolCop" type="submit" value="Send this Report" />
		<input class="button" name="cancelFoolCop" id="cancelFoolCop" type="submit" value="Cancel" />
	</div>
</fieldset>

<div id="progress-indicator">

	<img alt="" src="/web/20100104083858im_/http://g.fool.com/art/newsletters/22/site/icn_progress.gif" />

	<h3>Sending report...</h3>

</div>

	
	
	<!-- AdA.Master -->
	<!--googleoff:all-->
	<div id="secondary" class="column">
	    
		<div class="round clearfix">
  <div id="mainStoryPromo" class="component clearfix">
    <h5>The Must-Read Story on Fool.com</h5>
    <div class="content">
      <h5>
        <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/the-motley-fools-2009-year-in-review-and-predictio.aspx" class="qsAdd qs-source-irysithln0000001">The Fool's 2009 Year in Review and 2010 Predictions</a>
      </h5>
      <p>By The Motley Fool</p>
    </div>
    <a href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/the-motley-fools-2009-year-in-review-and-predictio.aspx" class="qsAdd qs-source-irysitima0000001">
      <img src="/web/20100104083858im_/http://g.fool.com/img/editorial/calendar1231.jpg" alt="The Fool's 2009 Year in Review and 2010 Predictions" height="68" width="112" />
    </a>
  </div>
</div>

			
		
		<div class="ad-336x280">
			<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x280;ptile=6;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x280;ptile=6;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x280;ptile=6;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		</div>
		
		
		
		
		
		<div class="round clearfix">

			
			
			<div id="recommendedHeadlines" class="recommendedHeadlines headlinesBox component">
  <h3>Most Popular Articles</h3><a name="recommendedHeadlines"></a><ol>
    <li><a title="Which investments will make you the most money in the coming year?" class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/30/the-best-stocks-for-2010.aspx">The Best Stocks for 2010</a><span>4 days ago</span></li>
    <li><a title="Why in the world are people still buying these stocks?" class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/29/the-daily-walk-of-shame-fannie-and-freddie.aspx">The Daily Walk of Shame: Fannie and Freddie</a><span>5 days ago</span></li>
    <li><a title="I'm not going to need a new Mac for a while." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/30/apples-going-to-hate-me.aspx">Apple's Going to Hate Me</a><span>4 days ago</span></li>
    <li><a title="Ford has some new toys in the works." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/29/will-ford-run-sirius-xm-off-the-road.aspx">Will Ford Run Sirius XM Off the Road?</a><span>5 days ago</span></li>
    <li><a title="Our best of what's behind and what's ahead." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/31/the-motley-fools-2009-year-in-review-and-predictio.aspx">The Motley Fool's 2009 Year in Review and Predictions for 2010</a><span>3 days ago</span></li>
    <li><a title="I wouldn't touch these companies." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/30/3-stocks-to-avoid-in-2010.aspx">3 Stocks to Avoid in 2010</a><span>4 days ago</span></li>
    <li><a title="This counterintuitive move could save you money." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/how-to-invest/personal-finance/taxes/2009/12/28/do-this-in-the-next-3-days-or-youll-regret-it.aspx">Do This in the Next 3 Days or You'll Regret It</a><span>6 days ago</span></li>
    <li><a title="Over the long haul, innovative companies provide you with the best chance for stellar returns." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/12/31/stocks-for-the-next-decade.aspx">Stocks for the Next Decade</a><span>3 days ago</span></li>
    <li><a title="Vote for the gold standard of silver investments." class="&#xA;									qsAdd qs-source-ihpdspmra0000001&#xA;								" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/30/the-best-stocks-for-2010-silver-wheaton.aspx">The Best Stocks for 2010: Silver Wheaton</a><span>4 days ago</span></li>
  </ol>
</div>
		</div>
		
		<div class="ad-336x280">
			<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x281;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x281;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=336x281;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
		</div>
		
		<div class="round clearfix">
			

<div id="relatedTickers" class="component">
	<h3>
		Related Tickers
	</h3>
	<div class="timestamp">
		12/31/2009 4:00 PM
	</div>


	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/PFE.aspx" class="qsAdd qs-source-irlsitlnk0000001">PFE</a>
				</td>
				<td class="currentPrice">
					$18.19
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_red.gif" height="11" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
					-0.31
				</td>
				<td class="pricePercentChange neg">
					-1.68%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Pfizer, Inc.
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/AMLN.aspx" class="qsAdd qs-source-irlsitlnk0000001">AMLN</a>
				</td>
				<td class="currentPrice">
					$14.19
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_green.gif" height="11" width="17" alt="Up" />
				</td>
				<td class="priceChange pos">
					+0.06
				</td>
				<td class="pricePercentChange pos">
					+0.42%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Amylin Pharmaceuti&#8230;
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/DNDN.aspx" class="qsAdd qs-source-irlsitlnk0000001">DNDN</a>
				</td>
				<td class="currentPrice">
					$26.28
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_red.gif" height="11" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
					-0.12
				</td>
				<td class="pricePercentChange neg">
					-0.45%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Dendreon Corp
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="**" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_two.gif" 
						class="infoTip" 
						title="2 Stars: Unattractive" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/MRK.aspx" class="qsAdd qs-source-irlsitlnk0000001">MRK</a>
				</td>
				<td class="currentPrice">
					$36.54
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_red.gif" height="11" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
					-0.52
				</td>
				<td class="pricePercentChange neg">
					-1.40%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Merck & Co., Inc.
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/MNKD.aspx" class="qsAdd qs-source-irlsitlnk0000001">MNKD</a>
				</td>
				<td class="currentPrice">
					$8.76
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_green.gif" height="11" width="17" alt="Up" />
				</td>
				<td class="priceChange pos">
					+0.01
				</td>
				<td class="pricePercentChange pos">
					+0.11%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					MannKind Corp
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="**" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_two.gif" 
						class="infoTip" 
						title="2 Stars: Unattractive" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/VVUS.aspx" class="qsAdd qs-source-irlsitlnk0000001">VVUS</a>
				</td>
				<td class="currentPrice">
					$9.20
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_red.gif" height="11" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
					-0.11
				</td>
				<td class="pricePercentChange neg">
					-1.18%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					VIVUS, Inc.
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="***" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_three.gif" 
						class="infoTip" 
						title="3 Stars: Appealing" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



	<table class="relatedTicker" cellpadding="0" cellspacing="0">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
					<a href="/web/20100104083858/http://caps.fool.com/ticker/LLY.aspx" class="qsAdd qs-source-irlsitlnk0000001">LLY</a>
				</td>
				<td class="currentPrice">
					$35.71
				</td>
				<td class="movementDirection">
					<img src="/web/20100104083858im_/http://g.fool.com/img/Article/relatedTickers/lg_arrows_red.gif" height="11" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
					-0.46
				</td>
				<td class="pricePercentChange neg">
					-1.27%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Eli Lilly & Co.
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="/web/20100104083858im_/http://g.fool.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



</div>


			

		<div id="relatedArticles" class="headlinesBox component">
			<h3>
				Related Articles
			</h3>
			
					<ul>
				
					<li>
						<a title="This Rally Is Ridiculous"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/value/2010/01/02/this-rally-is-ridiculous.aspx">This Rally Is Ridiculous</a>
						<span class="ticker"> - MRK</span>
						<span>1/2/2010 8:00 AM</span>
					</li>
				
					<li>
						<a title="A Healthy Way to Juice Your Stock's Yield"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/dividends-income/2009/12/31/a-healthy-way-to-juice-your-stocks-yield.aspx">A Healthy Way to Juice Your Stock's Yield</a>
						<span class="ticker"> - LLY</span>
						<span>12/31/2009 12:41 PM</span>
					</li>
				
					<li>
						<a title="Pfizer Pflubs -- You Expected Otherwise?"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/value/2009/12/30/pfizer-pflubs-you-expected-otherwise.aspx">Pfizer Pflubs -- You Expected Otherwise?</a>
						<span class="ticker"> - PFE</span>
						<span>12/30/2009 3:22 PM</span>
					</li>
				
					<li>
						<a title="Some Brand-Name Patents: Going, Going, Gone in 2010"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/high-growth/2009/12/29/some-brand-name-patents-going-going-gone-in-2010.aspx">Some Brand-Name Patents: Going, Going, Gone in 2010</a>
						<span class="ticker"> - MRK</span>
						<span>12/29/2009 4:13 PM</span>
					</li>
				
					<li>
						<a title="5 Superball Stocks"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/general/2009/12/28/5-superball-stocks.aspx">5 Superball Stocks</a>
						<span class="ticker"> - MRK</span>
						<span>12/28/2009 2:30 PM</span>
					</li>
				
					<li>
						<a title="2 Dividend Stocks Showing You the Money"  class="qsAdd qs-source-irasitlnk0000001" href="/web/20100104083858/http://www.fool.com/investing/dividends-income/2009/12/28/2-dividend-stocks-showing-you-the-money.aspx">2 Dividend Stocks Showing You the Money</a>
						<span class="ticker"> - MRK</span>
						<span>12/28/2009 10:30 AM</span>
					</li>
				
					</ul>
				
		</div>
		</div>
		
		<div class="sideBySideAds clearfix">
			<div class="left">
				<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=right_1;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
			</div>
			<div class="right">
				<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=right_2;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=right_2;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=right_2;seg=default;src=;sz=125x125;ptile=0;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>
			</div>
		</div>
		
		<div class="round clearfix fixedInsideParent">
  <div id="communityActionsBox" class="component wiki">
    <h3>
      <span>Community:</span>
			 Investing Wiki
		 </h3>
    <h5>Term Of The Hour</h5>
    <p class="definition">
      <a href="/web/20100104083858/http://wiki.fool.com/London_Interbank_Offered_Rate" class="&#xA;&#x9;&#x9;&#x9;&#x9;&#x9;qsAdd qs-source-iabsitlnk0000001&#xA;&#x9;&#x9;&#x9;&#x9;">London Interbank Offered Rate:
			</a> The London Interbank Offered Rate, commonly dubbed the LIBOR, is an interest rate at which banks lend each other money.</p>
    <p class="wikiAction">
      <a href="/web/20100104083858/http://wiki.fool.com/London_Interbank_Offered_Rate" class="&#xA;&#x9;&#x9;&#x9;&#x9;&#x9;betterDef qsAdd qs-source-iabsitlnk0000002&#xA;&#x9;&#x9;&#x9;&#x9;">
				Want to learn more or edit this definition?
			</a>
      <br />
      <a href="/web/20100104083858/http://wiki.fool.com/London_Interbank_Offered_Rate" class="&#xA;&#x9;&#x9;&#x9;&#x9;&#x9;qsAdd qs-source-iabsitlnk0000002&#xA;&#x9;&#x9;&#x9;&#x9;">
				Click here to read more!
			</a>
    </p>
  </div>
</div>
		
	</div><!-- /secondary -->
	<!--googleon:all-->
	<!-- /AdA.Master -->

	<!-- /ArticlesContent.Master -->


        </div>
    </form>

		</div>
	</div>

		<script src="/web/20100104083858js_/http://g.fool.com/js/getClientEnvironment.js?v=62615b" type="text/javascript"></script>
	
		<!--googleoff: all--><br clear="all"><div id="footer">
  <div class="grid">
    <div class="column span-25">
      <ul>
        <li class="first"><a href="/web/20100104083858/http://www.fool.com/" class="qsAdd qs-source-ihpftrlnk0000001" title="Home">Home</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/Press/History.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="About The Motley Fool">About The Motley Fool</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=about02&ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Fool Disclosure">Fool Disclosure</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/Press/FoolsInNewsprint.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Newspaper Column">Newspaper Column</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/Jobs/?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Work at The Fool">Work at The Fool</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=about01&ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Member Services">Member Services</a></li>
      </ul>
      <ul>
        <li class="first"><a href="/web/20100104083858/http://www.fool.com/media/advertising/advertising.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Advertise with The Fool">Advertise with The Fool</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=newuser03" class="qsAdd qs-source-ihpftrlnk0000001" title="Privacy Policy">Privacy Policy</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/Account/Freemailsubscribe.aspx?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Email Subscriptions">Email Subscriptions</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/about/headlines/rss.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="RSS Headlines"><img alt="RSS" class="rssLogo" src="/web/20100104083858im_/http://g.fool.com/img/rss.gif"> RSS Headlines</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=default&ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Help">Help</a></li>
        <li><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=morehelp01&ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Site Map">Site Map</a></li>
        <li><a href="/web/20100104083858/http://www.fool.co.uk/" class="qsAdd qs-source-ihpftrlnk0000001" title="Fool UK"><img alt="Fool UK" class="foolUkLogo" src="/web/20100104083858im_/http://g.fool.com/img/uk.gif"> Fool UK</a></li>
      </ul>
      <ul id="foolFriends">
        <li class="first">Fool Friends: </li>
        <li class="first"><a rel="nofollow" href="/web/20100104083858/http://finance.yahoo.com/" target="_new" title="Yahoo Finance">Yahoo Finance</a></li>
        <li><a rel="nofollow" href="/web/20100104083858/http://www.money.msn.com/" target="_new" title="MSN Money">MSN Money</a></li>
        <li><a rel="nofollow" href="/web/20100104083858/http://money.aol.com/" target="_new" title="AOL Money">AOL Money</a></li>
        <li><a rel="nofollow" href="/web/20100104083858/http://www.mint.com/" target="_new" title="Mint">Mint Personal Finance</a></li>
        <li><a rel="nofollow" href="/web/20100104083858/http://www.percussion.com/" target="_new" title="Percussion Software">Percussion Software</a></li>
      </ul>
    </div>
    <p class="legal"><a href="/web/20100104083858/http://www.fool.com/help/index.htm?display=about03&ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Legal Information">Legal Information</a>
					Â© 1995 -
					2010
					The Motley Fool. All rights reserved.
				</p>
    <p class="attrib">
					Market Data provided by <img alt="Interactive Data" class="idcLogo" src="/web/20100104083858im_/http://g.fool.com/img/topNav/idc.gif">&nbsp;<a href="javascript:void(0);" onclick="javascript:var win = window.open('/web/20100104083858/http://caps.fool.com/idcterms.htm', '','width=400,height=300,status=0,resizable=yes,scrollbars=yes');return false;" title="Interactive Data Terms &amp; Conditions. Opens in a new browser window.">Terms &amp; Conditions</a></p>
  </div>
  <div id="fn-serverinfo">109ms USEQ\EQWEBA10
<!-- do not remove this comment --><!-- size mapping  failed --></div><script type="text/javascript"><!--
				function openSurveyPop()
				{
					window.open("/web/20100104083858/http://www.foolinsights.com/se.ashx?s=04BD76CC764B44A9&sid=1&uid=1347602312", "myWindow", "status = 1, height = 700, width = 900, resizable = 1, scrollbars=2");
					return true;
				}
			//--></script><script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;ptile=9;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;ptile=9;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;ptile=9;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript></div><script type="text/javascript">
			var _gaq = _gaq || [];
			_gaq.push(['_setAccount', 'UA-3262475-1']);
			_gaq.push(['_trackPageview']);

			(function() {
			var ga = document.createElement('script');
			ga.src = ('https:' == document.location.protocol ? '/web/20100104083858/https://ssl' :
			'/web/20100104083858/http://www') + '.google-analytics.com/ga.js';
			ga.setAttribute('async', 'true');
			document.documentElement.firstChild.appendChild(ga);
			})();
		</script><script type="text/javascript">_qacct = "p-77sCb6T55qLV6";</script><script type="text/javascript" src="/web/20100104083858js_/http://secure.quantserve.com/quant.js"></script><noscript><a href="/web/20100104083858/http://www.quantcast.com/p-77sCb6T55qLV6" target="_blank"><img style="display: none;" border="0" height="1" width="1" alt="Quantcast" src="/web/20100104083858im_/http://secure.quantserve.com/pixel/p-77sCb6T55qLV6.gif"></a></noscript><!--googleon: all-->
		
	
	
	
	<iframe id="interrupt" frameborder="0" scrolling="no" name="interrupt" src="/web/20100104083858if_/http://www.fool.com/marketing/registrationinterrupt.aspx?ArticleHeadline=2010+FDA+Decisions+to+Watch&ReturnUrl=http%253a%252f%252fwww.fool.com%252finvesting%252fgeneral%252f2009%252f12%252f31%252f2010-fda-decisions-to-watch.aspx"></iframe>
	<script language="JavaScript" type="text/javascript" src="/web/20100104083858js_/http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;ptile=10;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default"></script><noscript><a href="/web/20100104083858/http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;ptile=10;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" rel="nofollow" target="_blank"><img src="/web/20100104083858im_/http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;ptile=10;ord=42146715;sub=default;port=default;trades=default;reg=false;uid=1347602312;ticker=default" border="0" alt=""></a></noscript>


	




	</body>

</html>





<!--
     FILE ARCHIVED ON 8:38:58 Jan 4, 2010 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 21:20:18 May 31, 2013.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
